Beyond the Microscopic

The Era of Precision Surgery at Cellular Level

About us

Dendrite refers to the protrusions of neuron cell bodies, representing the smallest cellular structures visible under an optical microscope. Our company is named "Dendrite" to reflect our commitment to the relentless pursuit of precision in optical imaging technology, striving to extend the boundaries of human vision.

Dendrite Precision has specialized in precision optical medical technology development for over 10 years and stands as a global leader in ultra-micro optical systems technology. We are dedicated to creating innovative medical technologies that provide clinicians with precise and safe surgical solutions, allowing patients worldwide to benefit from advanced precision surgeries. Dendrite Precision pioneered the development of the EndoScell™ intraoperative handheld microscope, which is based on needle-type microscope technology. It is currently the world’s only device capable of intraoperative in vivo cellular-level imaging, establishing a new benchmark in the era of cell-level precision surgery.

Corporate Values

RESPONSIBTY

RESPONSIBTY
Be responsible to patients, customers and yourself.

VALUE

VALUE
Create long-term value for shareholders and society.

INNOVATE

INNOVATE
Dare to lead and be pioneers.
Corporate Culture

L
Learning
I
Innovation
G
Growth
H
Harmony
T
Teamwork
History

2013
2015
2017
2018
2019
2020
2021
2022
2023
2024
  • March
    Founded the MCI brand.
  • February
    Completed development of high N.A. lens.
  • February
    Supplied high-end objective lenses for Olympus two-photon microscopes.
  • May
    Headquartered in Shanghai and renamed as Dendrite Precision; secured first-round financing with a valuation of RMB 200 million.
  • July
    Completed development of wide-field lens.
  • May
    Completed development of contact micro lens.
  • April
    Passed FDA 510(k) Pre-submission communication.
  • October
    Completed development of ultra-micro optical image stabilization system.
  • November
    Initiated the first clinical application in neurosurgery collaboration with Huashan Hospital (ITT).
  • April
    Completed the second round of financing with a valuation of RMB 512 million.
  • May
    Completed the prototype and developed endoscope sheath consumables.
  • May
    Established a Dendrite Precision subsidiary in the U.S. and launched the U.S. market.
  • January
    Obtained the NMPA Class II medical device certificate.
  • March
    Launched the first new product, MES-1000.
  • November
    Hefei High-tech Zone invested 550 million yuan and 50 acres of land to build a production base and headquarters for future public listing.
  • January
    Listed as the “Jiangsu Provincial Brain Glioma Genetic Diagnosis and Precision Treatment Engineering Research Center".
  • May
    Launched a nationwide, multicenter, prospective cohort study on: Intraoperative cell-microscope-assisted precision resection of glioblastoma.

2013

2015

2017

2018

2019

2020

2021

2022

2023

2024

Honorary

  • Patent Certificates
  • Social Honors
Contact Us

  • Hefei
  • Suzhou
  • Shanghai
  • Changsha

0512-68230287

dendriteprecision@scellmed.com

13th Floor, Building A1, Zhongan Chuanggu, No. 900, Wangjiang West Road, Hefei Hi-Tech Zone, Anhui Province

0512-68230287

dendriteprecision@scellmed.com

Room 301, Building 3, Software Park, 78 Keling Road, High-Tech Zone, Suzhou

0512-68230287

dendriteprecision@scellmed.com

Room 329, Building 3, Lane 1466, Shenchang Road, Minhang District, Shanghai

0512-68230287

dendriteprecision@scellmed.com

Room 703, Building 3, Standard Building, Shihe Pharmaceutical and Health Industry Park, No. 1048 Zhongqing Road, Shaping Street, Kaifu District, Changsha City, Hunan Province